Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice

Behavioural Brain Research

Volumn 250, Issue , 2013, Pages 308-315

  Mascarenhas, Diego Cardozo ^a   Gomes, Karina Santos ^a   Nunes de Souza, Ricardo Luiz ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Anxiety; Capsaicin; Capsazepine; Elevated plus maze; Mice; Periaqueductal gray matter

Indexed keywords

CAPSAICIN; CAPSAZEPINE; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR AGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BODY POSTURE; ETHOLOGY; EXPERIMENTAL MOUSE; HEAD MOVEMENT; HISTOPATHOLOGY; MAZE TEST; MOUSE; NEUROLOGIC EXAMINATION; NEUROMODULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN FUNCTION; SPATIOTEMPORAL ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CAPSAICIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; MALE; MAZE LEARNING; MICE; MICROINJECTIONS; PERIAQUEDUCTAL GRAY; TRPV CATION CHANNELS;

EID: 84879184006     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.05.023     Document Type: Article

References (41)

1. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
2. Szallasi A., Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacological Reviews 1999, 51:159-212.
3. Van der Stelt M., Di Marzo V. Endovanilloids: putative endogenous ligands of transient receptor potential vanilloid 1 channels. European Journal of Biochemistry 2004, 271:1827-1834.
4. Gewehr C., da Silva M.A., dos Santos G.T., Rossato M.F., de Oliveira S.M., Drewes C.C., et al. Contribution of peripheral vanilloid receptor to the nociception induced by injection of spermine in mice. Pharmacology Biochemistry and Behavior 2011, 99:775-781.
5. Akopian A.N., Ruparel N.B., Jeske N.A., Patwardhan A., Hargreaves K.M. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends in Pharmacological Sciences 2009, 30:79-84.
6. Terzian A.L., Aguiar D.C., Guimarães F.S., Moreira F.A. Modulation of anxiety-like behaviour by transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. European Neuropsychopharmacology 2009, 19:188-195.
7. Moreira F.A., Aguiar D.C., Campos A.C., Lisboa S.F., Terzian A.L., Resstel L.B., et al. Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?. Neural Plasticity 2009, 2009:625469.
8. Marinelli S., Di Marzo V., Florenzano F., Fezza F., Viscomi M.T., van der Stelt M., et al. Narachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology 2007, 32:298-308.
9. Mezey E., Tóth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:3655-3660.
10. McGaraughty S., Chu K.L., Bitner R.S., Martino B., El Kouhen R., Han P., et al. Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM. Journal of Neurophysiology 2003, 90:2702-2710.
11. Palazzo E., de Novellis V., Marabese I., Cuomo D., Rossi F., Berrino L., et al. Interaction between vanilloid and glutamate receptors in the central modulation of nociception. European Journal of Pharmacology 2002, 439:69-75.
12. Xing J., Li J. TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons. Journal of Neurophysiology 2007, 97:503-511.
13. Graeff F.G. Brain defense systems and anxiety. Handbook of anxiety 1990, 307-354. Elsevier Science Publishers, Amsterdam. G.D. Burrows, M. Roth, Noyers (Eds.).
14. Bandler R., Depaulis A., Vergnes M. Identification of midbrain neurons mediating defensive behaviors in the rat by microinjections of excitatory amino acids. Behavioural Brain Research 1985, 15:107-119.
15. Bandler R., Shipley M.T. Columnar organization in midbrain periaqueductal gray: modules of emotional expression?. Trends in Neurosciences 1994, 17:379-389.
16. Graeff F.G., Del-Ben C.M. Neurobiology of panic disorder: From animal models to brain neuroimaging. Neuroscience and Biobehavioral Reviews 2008, 32:1326-1335.
17. Valenstein E.S. Independence of approach and escape reactions to electrical stimulation of the brain. Journal of Comparative and Physiological Psychology 1965, 60:20-30.
18. Miguel T.T., Nunes-de-Souza R.L. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis. Brain Research 2006, 1076:42-48.
19. Kasckow J.W., Mulchahey J.J., Geracioti T.D. Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviours. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004, 28:291-295.
20. Lee C., Rodgers R.J. Antinociceptive effects of plus-maze exposure: influence of opiates receptor manipulations. Psychopharmacology 1990, 102:507-513.
21. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 1985, 14:149-167.
22. Taukulis H.K., Goggin C.E. Diazepam-stress interactions in the rat: effects on autoanalgesia and a plus-maze model of anxiety. Behavioral and Neural Biology 1990, 53:205-216.
23. Gomes K.S., Nunes-De-Souza R.L. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:1261-1269.
24. Miguel T.T., Nunes-de-Souza R.L. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice. Brain Research 2008, 1240:39-46.
25. Marsch R., Foeller E., Rammes G., Bunck M., Kössl M., Holsboer F., et al. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptordeficient mice. Journal of Neuroscience 2007, 27:832-839.
26. Rodgers R.J., Bickerdike P.A., Dingley H.K. Lack of effect of capsazepine, a TRPV1 receptor antagonist, on benzodiazepine-sensitive emotional behaviour in the mouse elevated plus-maze. Journal of Psychopharmacology 2010, 24(3):TG15. A76.
27. Micale V., Cristino L., Tamburella A., Petrosino S., Leggio G.M., Drago F., et al. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 2009, 34:593-606.
28. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.F. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. Journal of Neurophysiology 1991, 66:190-211.
29. Szallasi A., Di Marzo V. New perspectives on enigmatic vanilloid receptors. Trends in Neurosciences 2000, 23:491-497.
30. Paxinos G., Frankling K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego. 2nd ed.
31. Messier C., Emond S., Ethier K. New techniques in stereotaxic surgery and anesthesia in mice. Pharmacology Biochemistry and Behavior 1999, 63:313-318.
32. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92:180-185.
33. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacology Biochemistry and Behavior 1995, 52:297-303.
34. Campos A.C., Guimarães F.S. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:1517-1521.
35. Casarotto P.C., Terzian A.L., Aguiar D.C., Zangrossi H., Guimarães F.S., Wotjak C.T., et al. Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats. Neuropsychopharmacology 2012, 37:478-486.
36. Nunes-de-Souza R.L., Miguel T.T., Gomes K.S., Fugimoto J.S., Mendes-Gomes J., Amaral V.C.S., Carvalho-Netto E.F. Role of nitric oxide in the periaqueductal gray in defensive behavior in mice: influence of prior local N-methyl-D-aspartate receptor activation and aversive condition. Psychology and Neuroscience 2010, 3:59-66.
37. Carvalho-Netto E.F., Gomes K.S., Amaral V.C., Nunes-de-Souza R.L. Role of glutamate NMDA receptors and nitric oxide located within the periaqueductal gray on defensive behaviors in mice confronted by predator. Psychopharmacology 2009, 204:617-625.
38. Manna S.S., Umathe S.N. Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam. Brain Research 2011, 1425:75-82.
39. Fernández Espejo E. Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behavioural Brain Research 1997, 86:105-112.
40. Aguiar D.C., Terzian A.L., Guimarães F.S., Moreira F.A. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology 2009, 205:217-225.
41. Moreira F.A., Aguiar D.C., Guimarães F.S. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology 2007, 52:958-965.